Market Dynamics in Pharma and Retail

This chapter examines the market perception and valuation differences between pharmaceutical companies Novo and Lilly, highlighting investment opportunities and challenges. It also discusses the impact of U.S. tariffs on Chinese retail prices, featuring specific consumer goods and touching on the current state of the Chinese equity market.